NCT02182128View on ClinicalTrials.gov

A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2009

Conditions
Tumors
Interventions
DRUG

BIBF 1120

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY